<DOC>
	<DOCNO>NCT02401867</DOCNO>
	<brief_summary>The purpose study assess acceptability effectiveness utilizing vaginal self-swabs HPV DNA test compare provider-collected cervical swab HPV , well investigate prevalence Sexually Transmitted Infections ( STIs ) among sexually active female-to-male ( FTM ) transgender adult .</brief_summary>
	<brief_title>Preventive Sexual Health Screening Among Female-to-Male ( FTM ) Transgender Adult Patients</brief_title>
	<detailed_description>This observational study examine sexual health bio-behavioral cross-sectional mixed-methods design among 150 FTM patient Boston , Massachusetts , determine acceptability well collect epidemiologic data comparative performance characteristic several biological screen modality patient population . Patients stakeholder key partner throughout project involve phase study development , implementation , plan dissemination . Eligible participant participate one-time clinical visit . Following write consent , one-time clinical visit include : 1 ) Quantitative assessment ; 2 ) Collection biological specimens/biomarkers ( HPV DNA vaginal self-swab , HPV DNA cervical swab collect provider , Pap test cytology , STI test self- provider-collected ) ; 3 ) Qualitative Interview . A series national , online focus group FTMs , provider , key stakeholder occur gather information sexual health need FTM individual outside Boston area ensure dissemination study finding take differ demographic concern consideration .</detailed_description>
	<mesh_term>Sexually Transmitted Diseases</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Age 2164 Assigned female sex birth selfidentifies man , trans masculine , trans man , FTM , transgender , genderqueer/nonbinary , transsexual , male , and/or another diverse transgender identity expression Have cervix Sexually active past 36 month ( sexual partner ( ) gender ) Able speak understand English Willing able provide inform consent Unable provide inform consent due severe mental physical illness Substance intoxication time interview</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>transgender</keyword>
	<keyword>female-to-male</keyword>
	<keyword>cervical cancer</keyword>
	<keyword>HPV</keyword>
	<keyword>sexual health</keyword>
</DOC>